NCT01391182View on ClinicalTrials.gov

Epsilon Aminocaproic Acid (EACA) for the Reduction of Blood Loss in Total Hip Arthroplasty (THA)

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Degenerative Joint DiseaseOsteoarthritis
Interventions
OTHER

EACA

EACA 5 grams IV (mixed in NS) given in two doses: prior to incision (total hip arthroplasty) and repeated 4 hours later.

OTHER

Placebo arm

Placebo (NS) IV given in two doses: prior to incision (total hip arthroplasty) and repeated 4 hours later.

Trial Locations (1)

32224

Mayo Clinic Jacksonville, Jacksonville

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER